|Dr Ting's invitation to Leicester NIHR Cardiovascular Biomedical Research Unit
Dr. Choon Meng Ting (CEO and Chairman of Healthstats Singapore) has been invited to become an International Faculty Member of the Leicester NIHR Cardiovascular Biomedical Research Unit (BRU) based in the U.K.
The National Institute for Health Research (NIHR) provides the framework through which the research staff and research infrastructure of the NHS in England is positioned, maintained and managed as a national research facility. The NIHR provides the NHS with the support and infrastructure it needs to conduct first-class research funded by the Government and its partners alongside high-quality patient care, education and training. Its aim is to support outstanding individuals (both leaders and collaborators), working in world-class facilities (both NHS and university), conducting leading edge research focused on the needs of patients. www.nihr.ac.uk
The NIHR has established a series of disease specific biomedical research units (BRUs) as centres of excellence for translational research in the U.K. Leicester hosts one of the BRUs with specific expertise in Cardiovascular Diseases.
One of the missions of the NIHR BRUs is to foster collaborations with leading edge clinical research in industry to help translate new ideas into clinical practice. Professor Bryan Williams, an NIHR Senior Investigator and a member of the Leicester NIHR Cardiovascular BRU Executive team, is a leading International expert in high blood pressure and has worked in close collaboration with Dr. Ting and colleagues from Healthstats in Singapore, in developing the concept of non-invasive measurement of central aortic pressures. This has led to Healthstats to launch a series of innovative devices designed to take the measurement of central aortic pressure from the laboratory to main-stream clinical practice. Professor Williams said; “Dr. Ting and I met fortuitously at a conference some years ago and this has led to exciting scientific collaboration and a strong friendship. He is an inspirational and innovative entrepreneur who knows how to take a good idea from concept to practice. We want to change the way we measure blood pressure for the first time for more than a century. The work we have been doing is truly translational and will impact on the care of patients. I am really delighted that Dr. Ting has agreed to become an International Faculty member of the Leicester NIHR Cardiovascular BRU. It is recognition of his achievements and it will help foster even stronger scientific collaboration at a very exciting time for this field”. Dr Ting said….